Partial splenic embolization for liver cirrhosis accompanied by hypersplenism: an analysis of 39 cases

Lu Li,Zheng Zeng,Biao Yin,Xiao-Hong Lin,Hua Wan,Na Huo,Jing-Hang Xu,Xiao-Yuan Xu
DOI: https://doi.org/10.3969/j.issn.1009-3079.2007.11.024
2007-01-01
World Chinese Journal of Digestology
Abstract:AIM:To evaluate the efficacy of partial splenic embolization (PSE) in the treatment of patients with liver cirrhosis accompanied by hypersplenism and investigate the complications associated with PSE. METHODS:Thirty-seven cases of liver cirrhosis accompanied by hypersplenism who had re- ceived PSE (totally 39 times) were analyzed ret- rospectively.The observation time was from 0.1 to 60 months.The observation indexes included leukocyte count,hemoglobin,platelet count and side effects. RESULTS:After PSE,leukocyte and platelet counts were higher than those before PSE (P<0.05).No significant changes occurred in he- moglobin after PSE (except 15 months).Larger- area embolization produced a better efficacy than smaller-area one in short term,but not in long term.The side effects that happened most frequently were abdominal pain (94.9%) and fever (100%),and other ones included electro- lyte disorder (12.8%),pleura effusion (30.8%) and peritonitis (30.8%).Severe side effects were fulminant hepatitis (7.7%) and splenic abscess (5.1%).The incidence rate of fulminant hepatitis was higher in patients with Child C stage than that in A and B stage (40% vs 2.9%,P<0.05),and other side effects had no significant correlations with Child-Pugh classification and embolized area (P>0.05).The common side effects were more severe in patients with gigantic spleen. CONCLUSION:PSE is an effective method in the treatment of hypersplenism and the emboli- zed area should be determined according to the liver function of patients.
What problem does this paper attempt to address?